Tolerance Dose and Morphologic Changes in Murine Spinal Cord after Fractioned Irradiation with Fast Neutrons

1992 ◽  
Vol 15 (2) ◽  
pp. 151-155
Author(s):  
W. Wagner ◽  
E Gulotta
1973 ◽  
Vol 22 (3) ◽  
pp. 109-122 ◽  
Author(s):  
TETSUYA NAGASE ◽  
YUKIFUSA TANAKA ◽  
TADASHI WADA ◽  
TOKIO FUJIMAKI

2015 ◽  
Vol 49 (2) ◽  
pp. 185-191 ◽  
Author(s):  
Seung Heon Lee ◽  
Kyu Chan Lee ◽  
Jinho Choi ◽  
So Hyun Ahn ◽  
Seok Ho Lee ◽  
...  

Abstract Background. The aim of the study was to investigate whether biologically effective dose (BED) based on linearquadratic model can be used to estimate spinal cord tolerance dose in spine stereotactic body radiation therapy (SBRT) delivered in 4 or more fractions. Patients and methods. Sixty-three metastatic spinal lesions in 47 patients were retrospectively evaluated. The most frequently prescribed dose was 36 Gy in 4 fractions. In planning, we tried to limit the maximum dose to the spinal cord or cauda equina less than 50% of prescription or 45 Gy2/2. BED was calculated using maximum point dose of spinal cord. Results. Maximum spinal cord dose per fraction ranged from 2.6 to 6.0 Gy (median 4.3 Gy). Except 4 patients with 52.7, 56.4, 62.4, and 67.9 Gy2/2, equivalent total dose in 2-Gy fraction of the patients was not more than 50 Gy2/2 (12.1- 67.9, median 32.0). The ratio of maximum spinal cord dose to prescription dose increased up to 82.2% of prescription dose as epidural spinal cord compression grade increased. No patient developed grade 2 or higher radiationinduced spinal cord toxicity during follow-up period of 0.5 to 53.9 months. Conclusions. In fractionated spine SBRT, BED can be used to estimate spinal cord tolerance dose, provided that the dose per fraction to the spinal cord is moderate, e.g. < 6.0 Gy. It appears that a maximum dose of up to 45-50 Gy2/2 to the spinal cord is tolerable in 4 or more fractionation regimen.


2017 ◽  
Vol 12 (3) ◽  
pp. 224-229
Author(s):  
Sie Hyeon Yoo ◽  
Jin Hun Chung ◽  
Yonghan Seo ◽  
Min Kyung Choi ◽  
Won Kyu Choi ◽  
...  

1981 ◽  
Vol 88 (1) ◽  
pp. 165 ◽  
Author(s):  
Bernard C. Zook ◽  
Eileen W. Bradley ◽  
George W. Casarett ◽  
Mary Phyllis Fisher ◽  
Charles C. Rogers

1999 ◽  
Vol 97 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Keizo Yasui ◽  
Yoshio Hashizume ◽  
Mari Yoshida ◽  
Takashi Kameyama ◽  
G. Sobue

1979 ◽  
Vol 5 (6) ◽  
pp. 795-802 ◽  
Author(s):  
Eileen W. Bradley ◽  
Bernard C. Zook ◽  
George W. Casarett ◽  
Kenneth L. Mossman ◽  
Charles C. Rogers
Keyword(s):  

1974 ◽  
Vol 59 (2) ◽  
pp. 496 ◽  
Author(s):  
J. P. Geraci ◽  
P. D. Thrower ◽  
K. L. Jackson ◽  
G. M. Christensen ◽  
R. G. Parker ◽  
...  

Author(s):  
H Goyal ◽  
N Singh ◽  
O P Gurjar ◽  
R K Tanwar

Introduction: Cervical spinal cord is important and radiosensitive. It is the most critical organ for the head and neck (H&N) cancer patients during radiotherapy. If dos delivered to the cord is more than tolerance dose, demyelination may occur. Current study aims to analyze the post radiotherapy status of cord in the H&N cancer patients.Materials and Methods: Sixty patients who received more than 50 Gray (Gy) dose for more than 10 cm length of spinal cord participated in the study. All the patients were clinically examined and magnetic resonance imaging (MRI) was performed for patients who had demyelination symptoms. Adequate medical management was provided for all the patients having demyelination.Results: Out of sixty patients, ten cases were reported with demyelination symptoms, and only six cases gave consent for this study. One patient was found to have irreversible demyelination while five patients have reversible demyelination.Conclusions: Demyelination may occur if long segment spinal cord receives dose more than tolerance limit. However target dose should not be compromised up to 54 Gy to spinal cord.


Sign in / Sign up

Export Citation Format

Share Document